Medivice has workt together with Bielderman on the final stage of their new Pancreas Cancer Device. Bielderman will set up a European study to proof the safety and effectiveness’.
Medivice signed yesterday an exclusivity contract with Bielderman CRO for their cardiovascular and orthopedic devices. They made their decision on excellent work, very motivated people and their experience in a broad range of disciplines within Europe.
Today Paul Bielderman CEO of Bielderman CRO starts his Medical Device test Laboratory. It’s specialized in Phase 1 and 2 tests of Medical Devices.
This saves time for the Customer so that they will have a quicker access to safety requirements and gives them a better view in the possibilities of their device.
Medivice engages Bielderman CRO for their new device against colon cancer. The study will be started in 8 Countries with a total of 210 patients. The device is based on a High Tech technology and delivers a quick access to the polyp. More information will follow soon.
Interested in finding new medical distributors in France, Italy, Germany, the UK or other countries in Europe? Bielderman possess a specialized division in EDM Services that helps medical device manufacturers research and select medical distributors throughout Europe and other international markets such as Japan, Canada, Australia and the USA.
SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has engaged Bielderman BVBA, an experienced European contract research organization to manage the clinical process for its Barrett's esophageal cancer application under trial at certain European locations. Read more »
